49 related articles for article (PubMed ID: 2920950)
1. Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer.
Barter JF; Soong SJ; Shingleton HM; Hatch KD; Orr JW
Gynecol Oncol; 1989 Mar; 32(3):292-6. PubMed ID: 2920950
[TBL] [Abstract][Full Text] [Related]
2. Urological complications after radical hysterectomy with postoperative radiotherapy and radiotherapy alone for cervical cancer.
Li F; Guo H; Qiu H; Liu S; Wang K; Yang C; Tang C; Zheng Q; Hou Y
Medicine (Baltimore); 2018 Mar; 97(13):e0173. PubMed ID: 29595646
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Postoperative Pathologic Risk Factors in Cervical Cancer Patients Treated with Radical Hysterectomy by Machine Learning.
Ou Z; Mao W; Tan L; Yang Y; Liu S; Zhang Y; Li B; Zhao D
Curr Oncol; 2022 Dec; 29(12):9613-9629. PubMed ID: 36547169
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Prediction of Lymphovascular Space Invasion in Cervical Cancer With Radiomics -Based Nomogram.
Du W; Wang Y; Li D; Xia X; Tan Q; Xiong X; Li Z
Front Oncol; 2021; 11():637794. PubMed ID: 34322375
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the number of the metastatic lymph nodes in locally early-stage cervical cancer: squamous cell carcinoma versus non-squamous cell carcinoma.
Aslan K; Haberal A; Akıllı H; Meydanli MM; Ayhan A
Arch Gynecol Obstet; 2021 Nov; 304(5):1279-1289. PubMed ID: 33772630
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Resonance-Guided Radiation Therapy to Boost Cervical Cancer When Brachytherapy Is Not Available: A Case Report.
Sayan M; Mustafayev TZ; Atalar B; Gungor G; Ozyar E
Adv Radiat Oncol; 2020; 5(5):1066-1070. PubMed ID: 33083668
[No Abstract] [Full Text] [Related]
7. Evaluation of adjuvant chemotherapy after abdominal trachelectomy for cervical cancer: a single-institution experience.
Okugawa K; Yahata H; Sonoda K; Kodama K; Yagi H; Ohgami T; Yasunaga M; Onoyama I; Kaneki E; Asanoma K; Kobayashi H; Kato K
Int J Clin Oncol; 2021 Jan; 26(1):216-224. PubMed ID: 32880780
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Model for Survival and Recurrence in Patients with Early-Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028).
Paik ES; Lim MC; Kim MH; Kim YH; Song ES; Seong SJ; Suh DH; Lee JM; Lee C; Choi CH
Cancer Res Treat; 2020 Jan; 52(1):320-333. PubMed ID: 31401822
[TBL] [Abstract][Full Text] [Related]
9. Assessment of local treatment modalities for FIGO stage IB-IIB cervical cancer: A propensity-score matched analysis based on SEER database.
Song X; Han Y; Shao Y; Gu W; Pei H; Jiang J
Sci Rep; 2017 Jun; 7(1):3175. PubMed ID: 28600535
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenics and immunotherapies in cervical cancer: an update and future's view.
Luvero D; Plotti F; Lopez S; Scaletta G; Capriglione S; Montera R; Antonelli G; Ciuffreda S; Carassiti R; Oliveti A; Angioli R
Med Oncol; 2017 Jun; 34(6):115. PubMed ID: 28477178
[TBL] [Abstract][Full Text] [Related]
11. Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up.
Luvero D; Plotti F; Aloisi A; Capriglione S; Ricciardi R; Miranda A; Lopez S; Scaletta G; De Luca G; Benedetti-Panici P; Angioli R
Med Oncol; 2016 Oct; 33(10):110. PubMed ID: 27577931
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for early-stage cervical cancer.
Asano H; Todo Y; Watari H
Chin J Cancer Res; 2016 Apr; 28(2):228-34. PubMed ID: 27199521
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy.
Sun W; Wang T; Shi F; Wang J; Wang J; Hui B; Zhang Y; Lu J; Chen H; Liu Z
BMC Cancer; 2015 May; 15():353. PubMed ID: 25935645
[TBL] [Abstract][Full Text] [Related]
15. An Alternative Triage Strategy Based on Preoperative MRI for Avoiding Trimodality Therapy in Stage IB Cervical Cancer.
Lee JY; Youm J; Kim JW; Kim K; Kim HJ; Cho JY; Kim MA; Park NH; Song YS
Cancer Res Treat; 2016 Jan; 48(1):259-65. PubMed ID: 25797571
[TBL] [Abstract][Full Text] [Related]
16. Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer.
Lee TY; Jeung YJ; Lee CJ; Kim HY; Kim SH; Kim WG
Obstet Gynecol Sci; 2013 Jan; 56(1):15-21. PubMed ID: 24327975
[TBL] [Abstract][Full Text] [Related]
17. Application of gene expression programming and neural networks to predict adverse events of radical hysterectomy in cervical cancer patients.
Kusy M; Obrzut B; Kluska J
Med Biol Eng Comput; 2013 Dec; 51(12):1357-65. PubMed ID: 24136688
[TBL] [Abstract][Full Text] [Related]
18. Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix.
Baalbergen A; Veenstra Y; Stalpers L
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD006248. PubMed ID: 23440805
[TBL] [Abstract][Full Text] [Related]
19. Treatment options in recurrent cervical cancer (Review).
Gadducci A; Tana R; Cosio S; Cionini L
Oncol Lett; 2010 Jan; 1(1):3-11. PubMed ID: 22966247
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemoradiation after laparoscopically assisted vaginal radical hysterectomy (LARVH) in patients with cervical cancer: oncologic outcome and morbidity.
Gruen A; Musik T; Köhler C; Füller J; Wendt T; Stromberger C; Budach V; Schneider A; Marnitz S
Strahlenther Onkol; 2011 Jun; 187(6):344-9. PubMed ID: 21603992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
